New research highlights that neural stem cell-derived exosomes can alleviate neurodegeneration in Parkinson’s disease models induced by MPTP neurotoxins. These extracellular vesicles mediate neuroprotective effects and may represent a novel therapeutic avenue to restore neural function. The findings advance understanding of cell-free therapies that harness stem cell benefits while circumventing challenges of cell transplantation in neurodegenerative disorders.